This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, X.
Right arrow Articles by Yan, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, X.
Right arrow Articles by Yan, J.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, November 2008, p. 1711-1714, Vol. 15, No. 11
1071-412X/08/$08.00+0     doi:10.1128/CVI.00189-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Recombinant Multiepitope Protein for Diagnosis of Leptospirosis {triangledown}

Xu'ai Lin,1 Yin Chen,3 and Jie Yan1,2*

Department of Medical Microbiology and Parasitology, School of Medicine, Zhejiang University, Hangzhou 310058, China,1 Basic Medical Microbiology Division, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, School of Medicine, Zhejiang University, Hangzhou 310058, China,2 Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310009, China3

Received 27 May 2008/ Returned for modification 10 July 2008/ Accepted 19 September 2008

Leptospirosis is an emerging infectious disease and is considered to be the most widespread zoonotic disease in the world. It can be misdiagnosed because manifestations of this febrile disease vary from mild flu-like symptoms to severe illness involving vital organs such as the liver and lungs. Therefore, accurate diagnosis for differentiation of leptospirosis from other pyrogenic infections prevailing in the same locality is imperative for proper treatment. Here, we report a customized recombinant leptospirosis multiepitope protein (r-LMP) that can specifically detect the immunoglobulin class of anti-leptospirosis antibodies in patient sera. Immunodominant epitopes from leptospire outer membrane proteins OmpL1, LipL21, and LipL32 were predicted and confirmed using phage display and immunity reaction. On the basis of the sequences of the identified epitopes, five major immunodominant epitopes were selected to construct a synthetic gene, recombinant lmp. The recombinant lmp gene was doubled and expressed in Escherichia coli. The recombinant protein was purified and used as an antigen to develop an enzyme-linked immunosorbent assay for detection of special immunoglobulin M (IgM) or IgG in sera from patients with leptospirosis or other febrile illnesses and healthy subjects. The results showed that the r-LMP protein recognized IgG and IgM in all the sera that were microscope agglutination test positive, and there were no cross-reactions with other patient sera. This approach of creating customized antigens coupled to overexpression and simple purification offers a promising alternative option for leptospirosis diagnosis, with the potential to circumvent the drawbacks of whole-leptospirosis-antigen-based assays.

* Corresponding author. Mailing address: Department of Medical Microbiology and Parasitology, School of Medicine, Zhejiang University, 388 Yuhangtang Road, Hangzhou 310058, China. Phone and fax: 86-571-88208294. E-mail: med_bp{at}zju.edu.cn

{triangledown} Published ahead of print on 30 September 2008.

Clinical and Vaccine Immunology, November 2008, p. 1711-1714, Vol. 15, No. 11
1071-412X/08/$08.00+0     doi:10.1128/CVI.00189-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»